OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL

Catalog number BNUB3108-500

Price for BNUB3108-500

Size / count 1x 500 µL

About this product

ThisMAb recognizes a protein of 43 kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand/TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNUB3108-500
Size / count: 1x 500 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: ACT35; CD134; Lymphoid activation antigen ACT35; OX40; TAX transcriptionally-activated glycoprotein 1 receptor; TNFRSF4 (Tumor necrosis factor receptor superfamily member 4)
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: TNFRSF4
Gene ID: 7293
NCBI Gene ID: 129780
UniProt: P43489
Swiss Prot: P43489
Host: Mouse
Species Reactivity: Chimpanzee, Human
Reactivity: CD134, |OX40|TNFRSF4
Immunogen: Recombinant fragment of human OX40 (CD134) protein (around aa 59-205) (exact sequence is proprietary)
Target Antigen: CD134, | OX40 | TNFRSF4
Clonality: Monoclonal
Clone: OX40/3108
Type: Primary
Source: Animal
Origin: Animal
Applications: Flow (verified) |IF (verified) |IHC, FFPE (verified)
Positive Control: MOLT-4 cells. Human peripheral blood leukocytes (hPBL). Human tonsil tissue (IHC).
Stability: 2 years
Concentration: 0.2 mg/mL
Buffer: PBS, 0.05% BSA, 0.05% azide
Molecular Weight: 43 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG2c, kappa
Classification: PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate: Purified, with BSA

Frequently Asked Questions

What is the catalog number for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL?

The catalog number for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL is BNUB3108-500.

What sizes are available for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL?

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL is available in the following size(s): 1x 500 µL.

Is OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL in stock?

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL?

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL?

Estimated delivery time for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL?

The safety data sheet for OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0297061270361e10057f/msds/bnub3108-500.pdf.

What is OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL used for?

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Is this antibody conjugated?

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

What is the sensitivity of this ELISA kit?

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.